Microbicidal Gentamicin (cas 1403-66-3)-alginate hydrogels
-
Add time:09/08/2019 Source:sciencedirect.com
Sodium alginate (Alg) reacted with antibiotic gentamicin sulfate (GS) in an aqueous-phase condition mediated by carbodiimide chemistry, in the molar ratios Alg: GS of (1:0.5), (1:1) and (1:2). The Alg-GS conjugated derivatives were characterized by elemental analysis for nitrogen content, Fourier transform infrared spectroscopy in the attenuated total reflection mode (FTIR-ATR), X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), thermogravimetric analyses (TGA) and water sorption measurements. XPS and FTIR-ATR analyses clearly indicated that GS molecules covalently attached to the backbone of the alginate chains by amide bond formation. The highest amount of GS bound to Alg (43.5 ± 0.4 wt%) and the highest swelling ratio (4962 ± 661%) were observed for the Alg-GS (1:2) sample. Bioluminescence assays with Pseudomonas aeruginosa PAO1/lecA:lux and colony forming counting of Staphylococcus aureus and Escherichia coli upon contact with all Alg-GS conjugates revealed microbicidal activity; however, Alg-GS (1:2) was the most efficient, due to the highest GS content.
We also recommend Trading Suppliers and Manufacturers of Gentamicin (cas 1403-66-3). Pls Click Website Link as below: cas 1403-66-3 suppliers
Prev:Synthesis of Gentamicin (cas 1403-66-3)-grafted-chitosan with improved solubility and antibacterial activity
Next:Electrospinning of silica nanoparticles-entrapped nanofibers for sustained Gentamicin (cas 1403-66-3) release) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research paperEvaluation of collagen/hydroxyapatite electrospun layers loaded with vancomycin, Gentamicin (cas 1403-66-3) and their combination: Comparison of release kinetics, antimicrobial activity and cytocompatibility09/10/2019
- Electrospinning of silica nanoparticles-entrapped nanofibers for sustained Gentamicin (cas 1403-66-3) release09/09/2019
- Synthesis of Gentamicin (cas 1403-66-3)-grafted-chitosan with improved solubility and antibacterial activity09/07/2019
- Controllable delivery from Gentamicin (cas 1403-66-3) loaded polycaprolactone/grafted silica nanoparticles composite mats09/06/2019
- Improving Gentamicin (cas 1403-66-3) B and Gentamicin (cas 1403-66-3) C1a production by engineering the glycosyltransferases that transfer primary metabolites into secondary metabolites biosynthesis09/05/2019
- Original articleEffect of Withania somnifera on Gentamicin (cas 1403-66-3) induced renal lesions in rats09/04/2019
- Intratympanic mixture Gentamicin (cas 1403-66-3) and dexamethasone versus dexamethasone for unilateral Meniere's disease09/03/2019
- Overproduction of Gentamicin (cas 1403-66-3) B in industrial strain Micromonospora echinospora CCTCC M 2018898 by cloning of the missing genes genR and genS09/02/2019
- Original ArticleStandard-dose Gentamicin (cas 1403-66-3) does not increase risk of patent ductus arteriosus09/01/2019